Practical 5 Chromosomal analysis Karyotyping
Cytogenetic examination Karyotyping Analysis of chromosomal abnormalities Numerical Changes in chromosomal number Structural  Changes in chromosomal structure Importance  Diagnostics of chromosomally conditioned syndromes Examination of risk for the offspring Diagnostics of tumors associated with chromosomal abnormalities
Cytogenetic examinations Prenatal Examinations of the fetus Postnatal Examination of an individual after the birth
Written test 10  minutes Don't forget to put down your name, your group and the test version. In multiple choice questions more than 1 statement could be correct. Don't write anything on the question sheet!
Cytogenetic examinations Prenatal Examinations of the fetus Postnatal Examination of an individual after the birth
Prenatal examinations fetus chorion amnion umbilical cord Chorionic villi sampling (CVS) Amniocentesis Cordocentesis 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. End of prenatal examinations Weeks of pregnancy
Chorionic villi
Chorionic villi sampling since 11th week of pregnancy Transabdominal CVS Transvaginal (transcervical) CVS –  biopsy from the placenta and examining the baby's chromosomes
Chorionic villi sampling Tissue of chorionic villi Examination under the stereomicroscope
Schedule of prenatal examinations Chorionic villi sampling Amniocentesis Cordocentesis 11. 16. 20. Pregnancy  (weeks) 12 th  – 20 th  week Ultrasound Biochemical test in 16 th  week AFP, hCG, E3, PAPP 24. End of prenatal examinations
Ultrasound examination i s  offer ed to all pregnant women An instrument called a transducer emits sound waves that bounce or echo off internal organs. This information is relayed to a computer, which produces an image on a nearby screen.
Ultrasound ultrasound scan, sonogram, or ultrasonography. A  diagnostic or screening procedure that uses high-frequency sound waves to create a picture of internal body structures, such as a developing fetus.
Ultrasound examination
Nuchal translucency normal increased on ultrasound it appears as a black space beneath the fetal skin. this black space that you will see measured during the ultrasound scan  between 11-14 weeks of pregnancy The fetus may be affected with the Down syndrome
Nuchal Translucency collection of fluid beneath the fetal skin in the region of the fetal neck and is present in all fetuses in early pregnancy.  The fluid collection is increased in many fetuses with Down syndrome and many other chromosomal abnormalities. normally less than 2.5mm and when increased (i.e.>2.5mm) may indicate the baby has Down syndrome or another chromosomal abnormality.  If the nuchal translucency is increased then pregnant woman will be offered chorionic villus sampling or amniocentesis.
Biochemical test T riple screen or quad screen a set of tests, which screen for genetic problems The test determines, and also measures the levels of:  alpha-fetoprotein (AFP)  estriol (E3) human chorionic gonadotropin (hCG) inhibin A (for the quad screen) This test is offered to all pregnant women.
Maternal Serum  Alpha-Fetoprotein (MSAFP) Alpha-fetoprotein (AFP) is a protein that is produced by the fetus' liver. Between weeks 15 and 20 of a pregnancy, a maternal serum alpha-fetoprotein (MSAFP) screen will be offered. The quantity of AFP that is considered normal depends upon many variables, including age, weight, race, and stage of pregnancy. Insulin-dependent diabetes also influences AFP levels. Of those women whose tests show high or low levels of AFP, only  two or three in 100 will have a child with a birth defect .  Up to 10% of results are positive, meaning you have high- or low-AFP levels. With a positive AFP, additional tests will be suggested to help determine the cause.
Amniocentesis 15 th  – 16 th  week of pregnancy
Amniocentesis can diagnose or rule out many possible birth defects.  Most often, it's used to spot common genetic defects (such as Down syndrome) and neural tube defects.  is usually performed at 15 to 18 weeks gestation, although it can be done as early as 11 or 12 weeks.
Amniocentesis
Amniocentesis is typically offered to women who Will be 35 or older when they give birth.  Have a screening test or exam result that indicates a possible birth defect or other problem.  Have had birth defects in previous pregnancies.  Have a family history of genetic disorders.
Risk of amniocentesis About one woman in every 200-400 women miscarry as a result of amniocentesis. Amniocentesis done during the first trimester carries a greater risk for miscarriage than amniocentesis done after the 15th week. Less than one woman in every 1,000 women develop a uterine infection after amniocentesis.
Cordocentesis percutaneous umbilical blood sampling (PUBS)  umbilical vein sampling fetal blood sampling since 20th week of pregnancy
Cordocentesis diagnostic procedure in which a doctor extracts a sample of fetal blood from the vein in the umbilical cord. Th e fetal  blood can be analyzed to detect chromosomal defects or other abnormalities.
Cordocentesis  – advantages and risks results are usually ready much faster than with amniocentesis. With cordocentesis, the results may be ready within 48 hours. With amniocentesis, results can take about two weeks.  The miscarriage rate after cordocentesis is about 1 – 2%.  As with amniocentesis, there is a risk of infection, cramping, and bleeding.
Prenatal examinations fetus chorion amnion umbilical cord Chorionic villi sampling (CVS) Amniocentesis Cordocentesis 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. End of all prenatal examinations Weeks of pregnancy
For all of invasive prenatal samplings written consent of the mother is necessary.
Cytogenetic examinations Prenatal Examinations of the fetus Postnatal Examination of an individual after the birth
Indications for postnatal chromosomal analysis Possible chromosomal abnormality Multiple anomalies or growth retardation Gonadal abnormalities Unexplained   mental retardation Infertility or multiple miscarriages Death of a fetus, death of a newborn child Occurrence of tumors
Tissues for postnatal karyotyping Peripheral blood Skin fibroblasts Bone marrow (leukemia) Tumor Autopsy material (in case of a death of patient)
How to take a blood sample for chromosomal analysis? Disinfect the site of injection with alcohol (not iodine solution) The blood should be taken to  heparin tube (heparin prevents blood clotting)
Cultivation of peripheral blood lymphocytes Add phytohemaglutinin to medium – highly immunogenic compound - stimulates blood lymphocytes proliferation At the end of cultivation – application of colcemide (disrupts the mitotic spindle) Hypotonization Fixation Staining
Solid staining of chromosomes We use only Giemsa-Romanowski solution 6 – 12 13 – 15 19 – 20 21 – 22 4 – 5
G-banding (GTG) Trypsin + Giemsa
Each G-band has concrete number : Xq27.3 Chromosome X with G-bands
Another methods of chromosome staining R-banding (reverse bands – opposite to G-bands) Q-banding (quinacrin banding) C-banding (staining of constitutive heterochromatin Ag-NOR (staining of satellites in acrocentric chromosomes)
HRT High resolution technique Special cultivation method that allows isolation of prometaphase chromsomes Very long chromosomes Identification of small rearrangements is possible
Tasks Arrange a karyotype (small box with chromosome photos + table with chromosomes) Observe human G-banded chromosomes (box with slides) Find the chromosomes or interphase nuclei on the slide using 10x objective lens. Change the objective magnification into 40x and observe chromosomes.  Compare the picture in the microscope with adjacent photo.   Results will be controlled by Mrs. TÅÆmovĆ”, Dr. DiblĆ­k or Dr. KoÄĆ”rek.
Description of a normal karyotype according to cytogenetic nomenclature (ISCN  200 5) Normal karyotype Male … 46,XY Female … 46,XX Total number of all chromosomes,   sex chromosomes 46,XY
Put the slides back to boxes, please.
Next practical Numerical chromosomal abnormalities No test!
See you next week!

More Related Content

PDF
Cancer metabolism lecture, Hood College (10-18-10)
PPTX
The Genetics of Cancer
PPT
Cancer biology
PPT
Chemotherapy in ovarian cancer
PPT
Genetic disorders 2
PPTX
Karyotyping
PPTX
Oncogenes
PPTX
Explanation of X-Linked inheritance
Cancer metabolism lecture, Hood College (10-18-10)
The Genetics of Cancer
Cancer biology
Chemotherapy in ovarian cancer
Genetic disorders 2
Karyotyping
Oncogenes
Explanation of X-Linked inheritance

What's hot (20)

PPTX
Metastatic cascade and Epithelial Mesenchymal Transition
PPTX
Introduction to Darwinian Evolution
PPTX
DNA SLIDES GRADE 12 LIFE SCIENCES
PPTX
Autosomal recessive disorders
PPTX
Prenatal diagnosis
PPTX
Gynecologic Tumor Markers
PPTX
Molecular basis of tumor
PPTX
Modes of inheritance
PPTX
Types of Inheritance
PPTX
Xeroderma Pigmentosum
PPT
Fundamentals of genetics
PDF
Genetics
PPTX
Metabolic Alterations in Cancer
PPTX
Transport across cell membrane
PPTX
Oncogenes
PPT
Genetic disorders
PPTX
Cancer and genes
PDF
Genetic basis of diseases (!)
PPTX
Classification of chromosome & karyotyping
PPTX
Sphingolipidoses
Metastatic cascade and Epithelial Mesenchymal Transition
Introduction to Darwinian Evolution
DNA SLIDES GRADE 12 LIFE SCIENCES
Autosomal recessive disorders
Prenatal diagnosis
Gynecologic Tumor Markers
Molecular basis of tumor
Modes of inheritance
Types of Inheritance
Xeroderma Pigmentosum
Fundamentals of genetics
Genetics
Metabolic Alterations in Cancer
Transport across cell membrane
Oncogenes
Genetic disorders
Cancer and genes
Genetic basis of diseases (!)
Classification of chromosome & karyotyping
Sphingolipidoses
Ad

Similar to Practical 5 07 (20)

PDF
DIAGNOSTICS.pdf GENETIC EVALUATION AND TREATMENT
PPTX
Prenatal Genetic Diagnosis
PPTX
pregnancy &prenatal diagnosisi
PPT
37233502 amniocentesis-and-cvs
PPT
Prenatal cytogenetic
PPTX
genetic tests.pptx
PPTX
Genetictesting 140305094745-phpapp01
PPTX
Fetal therapy
PPTX
Seminar prenatal genetic screening
PPTX
Antenatal monitoring of fetal well being 2
PPTX
high risk assessment.pptx
PPTX
GENETIC MUTATION.pptx (M.Sc Nursing ) I y
PPTX
UNIT 3 GENETICS.pptx
PPTX
Genetics Series Prenatal Diagnosis.pptx
PPTX
Matenal and fetal weebeing
PPTX
PRENATAL_DIAGNOSIS[1].pptx
PPTX
Screening of high risk pregnancy
PPTX
Genetic testing
PPTX
Sridhar prenatal diagnosis
PPTX
PharmaNiPTGeneticalDemographics MTY.pptx
DIAGNOSTICS.pdf GENETIC EVALUATION AND TREATMENT
Prenatal Genetic Diagnosis
pregnancy &prenatal diagnosisi
37233502 amniocentesis-and-cvs
Prenatal cytogenetic
genetic tests.pptx
Genetictesting 140305094745-phpapp01
Fetal therapy
Seminar prenatal genetic screening
Antenatal monitoring of fetal well being 2
high risk assessment.pptx
GENETIC MUTATION.pptx (M.Sc Nursing ) I y
UNIT 3 GENETICS.pptx
Genetics Series Prenatal Diagnosis.pptx
Matenal and fetal weebeing
PRENATAL_DIAGNOSIS[1].pptx
Screening of high risk pregnancy
Genetic testing
Sridhar prenatal diagnosis
PharmaNiPTGeneticalDemographics MTY.pptx
Ad

More from medik.cz (20)

PPT
Evolution Practicals
PPT
Praktikum 6 07
PPT
Praktikum 4 07
PPT
Praktikum 3 07
PPT
Practical 6 07
PPT
Practical 3 07
PPT
Practical 2 07
PPT
Konfokalni Mikroskopie
PPT
Evoluce I Idoplnena
PPT
Evoluce Bak
PPT
Eko Praktikum 2 06
PPT
Ecology Practicals2
PPT
Ecology1 Complete
PPT
Down Syndrome Child
PPT
Praktikum 7 07
PPT
Praktikum 5 07
PPT
Praktikum 2 07
PPT
Praktikum 1 07
PPT
Practical 7 07
PPT
Practical 4 07
Evolution Practicals
Praktikum 6 07
Praktikum 4 07
Praktikum 3 07
Practical 6 07
Practical 3 07
Practical 2 07
Konfokalni Mikroskopie
Evoluce I Idoplnena
Evoluce Bak
Eko Praktikum 2 06
Ecology Practicals2
Ecology1 Complete
Down Syndrome Child
Praktikum 7 07
Praktikum 5 07
Praktikum 2 07
Praktikum 1 07
Practical 7 07
Practical 4 07

Recently uploaded (20)

PPTX
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
PPTX
4. Abdominal Trauma 2020.jiuiwhewh2udwepptx
PDF
Lecture 8- Cornea and Sclera .pdf 5tg year
PPT
Opthalmology presentation MRCP preparation.ppt
PPTX
merged_presentation_choladeck (3) (2).pptx
PDF
AGE(Acute Gastroenteritis)pdf. Specific.
PPT
neurology Member of Royal College of Physicians (MRCP).ppt
PDF
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
PPTX
@K. CLINICAL TRIAL(NEW DRUG DISCOVERY)- KIRTI BHALALA.pptx
PPTX
Post Op complications in general surgery
PPTX
Physiology of Thyroid Hormones.pptx
PDF
Forensic Psychology and Its Impact on the Legal System.pdf
DOCX
PEADIATRICS NOTES.docx lecture notes for medical students
PDF
OSCE SERIES ( Questions & Answers ) - Set 5.pdf
PPTX
NUCLEAR-MEDICINE-Copy.pptxbabaabahahahaahha
PPT
Rheumatology Member of Royal College of Physicians.ppt
PPT
Dermatology for member of royalcollege.ppt
PDF
Nursing manual for conscious sedation.pdf
PPTX
Antepartum_Haemorrhage_Guidelines_2024.pptx
PPTX
CARDIOVASCULAR AND RENAL DRUGS.pptx for health study
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
4. Abdominal Trauma 2020.jiuiwhewh2udwepptx
Lecture 8- Cornea and Sclera .pdf 5tg year
Opthalmology presentation MRCP preparation.ppt
merged_presentation_choladeck (3) (2).pptx
AGE(Acute Gastroenteritis)pdf. Specific.
neurology Member of Royal College of Physicians (MRCP).ppt
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
@K. CLINICAL TRIAL(NEW DRUG DISCOVERY)- KIRTI BHALALA.pptx
Post Op complications in general surgery
Physiology of Thyroid Hormones.pptx
Forensic Psychology and Its Impact on the Legal System.pdf
PEADIATRICS NOTES.docx lecture notes for medical students
OSCE SERIES ( Questions & Answers ) - Set 5.pdf
NUCLEAR-MEDICINE-Copy.pptxbabaabahahahaahha
Rheumatology Member of Royal College of Physicians.ppt
Dermatology for member of royalcollege.ppt
Nursing manual for conscious sedation.pdf
Antepartum_Haemorrhage_Guidelines_2024.pptx
CARDIOVASCULAR AND RENAL DRUGS.pptx for health study

Practical 5 07

  • 1. Practical 5 Chromosomal analysis Karyotyping
  • 2. Cytogenetic examination Karyotyping Analysis of chromosomal abnormalities Numerical Changes in chromosomal number Structural Changes in chromosomal structure Importance Diagnostics of chromosomally conditioned syndromes Examination of risk for the offspring Diagnostics of tumors associated with chromosomal abnormalities
  • 3. Cytogenetic examinations Prenatal Examinations of the fetus Postnatal Examination of an individual after the birth
  • 4. Written test 10 minutes Don't forget to put down your name, your group and the test version. In multiple choice questions more than 1 statement could be correct. Don't write anything on the question sheet!
  • 5. Cytogenetic examinations Prenatal Examinations of the fetus Postnatal Examination of an individual after the birth
  • 6. Prenatal examinations fetus chorion amnion umbilical cord Chorionic villi sampling (CVS) Amniocentesis Cordocentesis 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. End of prenatal examinations Weeks of pregnancy
  • 8. Chorionic villi sampling since 11th week of pregnancy Transabdominal CVS Transvaginal (transcervical) CVS – biopsy from the placenta and examining the baby's chromosomes
  • 9. Chorionic villi sampling Tissue of chorionic villi Examination under the stereomicroscope
  • 10. Schedule of prenatal examinations Chorionic villi sampling Amniocentesis Cordocentesis 11. 16. 20. Pregnancy (weeks) 12 th – 20 th week Ultrasound Biochemical test in 16 th week AFP, hCG, E3, PAPP 24. End of prenatal examinations
  • 11. Ultrasound examination i s offer ed to all pregnant women An instrument called a transducer emits sound waves that bounce or echo off internal organs. This information is relayed to a computer, which produces an image on a nearby screen.
  • 12. Ultrasound ultrasound scan, sonogram, or ultrasonography. A diagnostic or screening procedure that uses high-frequency sound waves to create a picture of internal body structures, such as a developing fetus.
  • 14. Nuchal translucency normal increased on ultrasound it appears as a black space beneath the fetal skin. this black space that you will see measured during the ultrasound scan between 11-14 weeks of pregnancy The fetus may be affected with the Down syndrome
  • 15. Nuchal Translucency collection of fluid beneath the fetal skin in the region of the fetal neck and is present in all fetuses in early pregnancy. The fluid collection is increased in many fetuses with Down syndrome and many other chromosomal abnormalities. normally less than 2.5mm and when increased (i.e.>2.5mm) may indicate the baby has Down syndrome or another chromosomal abnormality. If the nuchal translucency is increased then pregnant woman will be offered chorionic villus sampling or amniocentesis.
  • 16. Biochemical test T riple screen or quad screen a set of tests, which screen for genetic problems The test determines, and also measures the levels of: alpha-fetoprotein (AFP) estriol (E3) human chorionic gonadotropin (hCG) inhibin A (for the quad screen) This test is offered to all pregnant women.
  • 17. Maternal Serum Alpha-Fetoprotein (MSAFP) Alpha-fetoprotein (AFP) is a protein that is produced by the fetus' liver. Between weeks 15 and 20 of a pregnancy, a maternal serum alpha-fetoprotein (MSAFP) screen will be offered. The quantity of AFP that is considered normal depends upon many variables, including age, weight, race, and stage of pregnancy. Insulin-dependent diabetes also influences AFP levels. Of those women whose tests show high or low levels of AFP, only two or three in 100 will have a child with a birth defect . Up to 10% of results are positive, meaning you have high- or low-AFP levels. With a positive AFP, additional tests will be suggested to help determine the cause.
  • 18. Amniocentesis 15 th – 16 th week of pregnancy
  • 19. Amniocentesis can diagnose or rule out many possible birth defects. Most often, it's used to spot common genetic defects (such as Down syndrome) and neural tube defects. is usually performed at 15 to 18 weeks gestation, although it can be done as early as 11 or 12 weeks.
  • 21. Amniocentesis is typically offered to women who Will be 35 or older when they give birth. Have a screening test or exam result that indicates a possible birth defect or other problem. Have had birth defects in previous pregnancies. Have a family history of genetic disorders.
  • 22. Risk of amniocentesis About one woman in every 200-400 women miscarry as a result of amniocentesis. Amniocentesis done during the first trimester carries a greater risk for miscarriage than amniocentesis done after the 15th week. Less than one woman in every 1,000 women develop a uterine infection after amniocentesis.
  • 23. Cordocentesis percutaneous umbilical blood sampling (PUBS) umbilical vein sampling fetal blood sampling since 20th week of pregnancy
  • 24. Cordocentesis diagnostic procedure in which a doctor extracts a sample of fetal blood from the vein in the umbilical cord. Th e fetal blood can be analyzed to detect chromosomal defects or other abnormalities.
  • 25. Cordocentesis – advantages and risks results are usually ready much faster than with amniocentesis. With cordocentesis, the results may be ready within 48 hours. With amniocentesis, results can take about two weeks. The miscarriage rate after cordocentesis is about 1 – 2%. As with amniocentesis, there is a risk of infection, cramping, and bleeding.
  • 26. Prenatal examinations fetus chorion amnion umbilical cord Chorionic villi sampling (CVS) Amniocentesis Cordocentesis 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. End of all prenatal examinations Weeks of pregnancy
  • 27. For all of invasive prenatal samplings written consent of the mother is necessary.
  • 28. Cytogenetic examinations Prenatal Examinations of the fetus Postnatal Examination of an individual after the birth
  • 29. Indications for postnatal chromosomal analysis Possible chromosomal abnormality Multiple anomalies or growth retardation Gonadal abnormalities Unexplained mental retardation Infertility or multiple miscarriages Death of a fetus, death of a newborn child Occurrence of tumors
  • 30. Tissues for postnatal karyotyping Peripheral blood Skin fibroblasts Bone marrow (leukemia) Tumor Autopsy material (in case of a death of patient)
  • 31. How to take a blood sample for chromosomal analysis? Disinfect the site of injection with alcohol (not iodine solution) The blood should be taken to heparin tube (heparin prevents blood clotting)
  • 32. Cultivation of peripheral blood lymphocytes Add phytohemaglutinin to medium – highly immunogenic compound - stimulates blood lymphocytes proliferation At the end of cultivation – application of colcemide (disrupts the mitotic spindle) Hypotonization Fixation Staining
  • 33. Solid staining of chromosomes We use only Giemsa-Romanowski solution 6 – 12 13 – 15 19 – 20 21 – 22 4 – 5
  • 35. Each G-band has concrete number : Xq27.3 Chromosome X with G-bands
  • 36. Another methods of chromosome staining R-banding (reverse bands – opposite to G-bands) Q-banding (quinacrin banding) C-banding (staining of constitutive heterochromatin Ag-NOR (staining of satellites in acrocentric chromosomes)
  • 37. HRT High resolution technique Special cultivation method that allows isolation of prometaphase chromsomes Very long chromosomes Identification of small rearrangements is possible
  • 38. Tasks Arrange a karyotype (small box with chromosome photos + table with chromosomes) Observe human G-banded chromosomes (box with slides) Find the chromosomes or interphase nuclei on the slide using 10x objective lens. Change the objective magnification into 40x and observe chromosomes. Compare the picture in the microscope with adjacent photo. Results will be controlled by Mrs. TÅÆmovĆ”, Dr. DiblĆ­k or Dr. KoÄĆ”rek.
  • 39. Description of a normal karyotype according to cytogenetic nomenclature (ISCN 200 5) Normal karyotype Male … 46,XY Female … 46,XX Total number of all chromosomes, sex chromosomes 46,XY
  • 40. Put the slides back to boxes, please.
  • 41. Next practical Numerical chromosomal abnormalities No test!
  • 42. See you next week!